ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
P-229 Phase II evaluation of low dose suramin as a modulator of paclitaxel/carboplatin (P/C) in non-small cell lung cancer (NSCLC) patients
Lung Cancer
◽
10.1016/s0169-5002(03)92198-2
◽
2003
◽
Vol 41
◽
pp. S149
◽
Cited By ~ 3
Author(s):
Miguel A. Villalona-Calero
◽
G. Otterson
◽
G. Wientjes
◽
A. Murgo
◽
R. Jensen
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Low Dose
◽
Small Cell
◽
Small Cell Lung
◽
Nsclc Patients
Download Full-text
Related Documents
Cited By
References
Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung)
Annals of Oncology
◽
10.1093/annonc/mdz260.092
◽
2019
◽
Vol 30
◽
pp. v646-v647
◽
Cited By ~ 1
Author(s):
D. Heudobler
◽
C. Schulz
◽
J.R. Fischer
◽
P. Staib
◽
T. Wehler
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Low Dose
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Randomized Phase Ii
◽
Low Dose Chemotherapy
Download Full-text
MA21.11 A Multicenter Phase II Study of Low-Dose Erlotinib in Frail Patients with EGFR Mutation-Positive, Non-Small Cell Lung Cancer: TORG1425
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2019.08.681
◽
2019
◽
Vol 14
(10)
◽
pp. S338
Author(s):
S. Otani
◽
K. Yamada
◽
S. Miyamoto
◽
K. Azuma
◽
H. Ishii
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Low Dose
◽
Egfr Mutation
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(03)90818-4
◽
2003
◽
Vol 1
(5)
◽
pp. S238
◽
Cited By ~ 1
Author(s):
F. Cappuzzo
◽
S. Novello
◽
F. De Marinis
◽
M. Maur
◽
G. Scagliotti
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Locally Advanced
◽
Small Cell
◽
Small Cell Lung
◽
Multicenter Phase
◽
Nsclc Patients
Download Full-text
Abstract CT041: Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy
10.1158/1538-7445.am2019-ct041
◽
2019
◽
Cited By ~ 1
Author(s):
Peter Ordentlich
◽
Lei Wang
◽
David Tamang
◽
Amy H. Sullivan
◽
Sally E. Church
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Gene Signatures
◽
Nsclc Patients
Download Full-text
Randomised Phase II Trial of Oral Vinorelbine (N) and Cisplatin (P) or Pemetrexed and C (PC) in First Line Advanced Non Squamous (NSCC) Non Small Cell Lung Cancer (NSCLC) Patients (PTS). Navotrial01: Final Results
Annals of Oncology
◽
10.1016/s0923-7534(20)33841-2
◽
2012
◽
Vol 23
◽
pp. ix409
Author(s):
E.H. Tan
◽
L. Havel
◽
M.J. Krzakowski
◽
J. Kollmeier
◽
R. Gervais
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Oral Vinorelbine
◽
Nsclc Patients
Download Full-text
Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients
Cancer Gene Therapy
◽
10.1038/cgt.2009.15
◽
2009
◽
Vol 16
(8)
◽
pp. 620-624
◽
Cited By ~ 87
Author(s):
J Nemunaitis
◽
M Nemunaitis
◽
N Senzer
◽
P Snitz
◽
C Bedell
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Tumor Vaccine
◽
Small Cell
◽
Small Cell Lung
◽
Antisense Gene
◽
Nsclc Patients
Download Full-text
Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (cDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): A randomized three arm phase II study of the eortc lung cancer and radiotherapy cooperative groups
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/0360-3016(90)90020-k
◽
1990
◽
Vol 19
(4)
◽
pp. 967-972
◽
Cited By ~ 52
Author(s):
C. Schaake-Koning
◽
B.MaatP. Van Houtte
◽
W. van den Bogaert
◽
O. Dalesio
◽
A. Kirkpatrick
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Low Dose
◽
Phase Ii Study
◽
Small Cell
◽
Cooperative Groups
◽
Small Cell Lung
Download Full-text
Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A SWOG phase II trial (S0027)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7056
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7056-7056
◽
Cited By ~ 5
Author(s):
P. J. Hesketh
◽
K. Chansky
◽
D. H. Lau
◽
J. Crowley
◽
D. R. Gandara
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Performance Status
◽
Small Cell
◽
Small Cell Lung
◽
Nsclc Patients
Download Full-text
Phase II study of low dose suramin as a sensitizer of paclitaxel/carboplatin (P/C) in non small cell lung cancer (NSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.7108
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7108-7108
Author(s):
M. A. Villalona-Calero
◽
G. A. Otterson
◽
G. Wientjes
◽
K. Kobayashi
◽
R. Jensen
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Low Dose
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Phase II study of low-dose paclitaxel with timed thoracic radiotherapy (TTR) followed by gemcitabine and carboplatin consolidation in patients with unresectable stage III non-small cell lung cancer (NSCLC): NCT 00449657.
Journal of Clinical Oncology
◽
10.1200/jco.2011.29.15_suppl.7044
◽
2011
◽
Vol 29
(15_suppl)
◽
pp. 7044-7044
Author(s):
J. Zhang
◽
S. M. Russo
◽
H. A. Gay
◽
T. Parent
◽
Z. Nelson
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Low Dose
◽
Phase Ii Study
◽
Small Cell
◽
Thoracic Radiotherapy
◽
Small Cell Lung
◽
Unresectable Stage
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close